464
Views
42
CrossRef citations to date
0
Altmetric
Reviews

The association between obesity and colorectal adenoma: systematic review and meta-analysis

, , , &
Pages 136-146 | Received 25 Sep 2012, Accepted 03 Oct 2012, Published online: 06 Nov 2012

References

  • Jemal A, Bray F, Center MM, Ferlay J, Ward E, Forman D. Global cancer statistics. CA Cancer J Clin 2011;61:69–90.
  • Zauber AG, Winawer SJ, O'Brien MJ, Lansdorp-Vogelaar I, van Ballegooijen M, Hankey BF, Colonoscopic polypectomy and long-term prevention of colorectal-cancer deaths. N Engl J Med 2012;366:687–96.
  • Low S, Chin MC, Deurenberg-Yap M. Review on epidemic of obesity. Ann Acad Med Singapore 2009;38:57–9.
  • Gunter MJ, Leitzmann MF. Obesity and colorectal cancer: epidemiology, mechanisms and candidate genes. J Nutr Biochem 2006;17:145–56.
  • Guilera M, Connelly-Frost A, Keku TO, Martin CF, Galanko J, Sandler RS. Does physical activity modify the association between body mass index and colorectal adenomas? Nutr Cancer 2005;51:140–5.
  • Sedjo RL, Byers T, Levin TR, Haffner SM, Saad MF, Tooze JA, Change in body size and the risk of colorectal adenomas. Cancer Epidemiol Biomarkers Prev 2007;16:526–31.
  • Leitzmann MF, Flood A, Ferrucci LM, Schoenfeld P, Cash B, Schatzkin A, Adiposity in relation to colorectal adenomas and hyperplastic polyps in women. Cancer Causes Control 2009;20:1497–507.
  • Harriss DJ, Atkinson G, George K, Cable NT, Reilly T, Haboubi N, Lifestyle factors and colorectal cancer risk (1): systematic review and meta-analysis of associations with body mass index. Colorectal Dis 2009;11:547–63.
  • Ning Y, Wang L, Giovannucci EL. A quantitative analysis of body mass index and colorectal cancer: findings from 56 observational studies. Obes Rev 2010;11:19–30.
  • Ben Q, An W, Jiang Y, Zhan X, Du Y, Cai QC, Body mass index increases risk for colorectal adenomas based on meta-analysis. Gastroenterology 2012;142:762–72.
  • Stroup DF, Berlin JA, Morton SC, Olkin I, Williamson GD, Rennie D, Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group. JAMA 2000;283:2008–12.
  • Chia VM, Newcomb PA, Lampe JW, White E, Mandelson MT, McTiernan A, Leptin concentrations, leptin receptor polymorphisms, and colorectal adenoma risk. Cancer Epidemiol Biomarkers Prev 2007;16:2697–703.
  • Sato Y, Nozaki R, Yamada K, Takano M, Haruma K. Relation between obesity and adenomatous polyps of the large bowel. Dig Endosc 2009;21:154–7.
  • Otake T, Uezono K, Takahashi R, Fukumoto J, Tabata S, Abe H, C-reactive protein and colorectal adenomas: Self Defense Forces Health Study. Cancer Sci 2009;100:709–14.
  • Higgins JP, Thompson SG. Quantifying heterogeneity in a meta-analysis. Stat Med 2002;21:1539–58.
  • Otake S, Takeda H, Suzuki Y, Fukui T, Watanabe S, Ishihama K, Association of visceral fat accumulation and plasma adiponectin with colorectal adenoma: evidence for participation of insulin resistance. Clin Cancer Res 2005;11:3642–6.
  • Lim YJ, Kwack WG, Lee YS, Hahm KB, Kim YK. Increased pulse wave velocity reflecting arterial stiffness in patients with colorectal adenomas. J Clin Biochem Nutr 2010;47:261–5.
  • Stadlmayr A, Aigner E, Steger B, Scharinger L, Lederer D, Mayr A, Nonalcoholic fatty liver disease: an independent risk factor for colorectal neoplasia. J Intern Med 2011;270:41–9.
  • Yamaji Y, Okamoto M, Yoshida H, Kawabe T, Wada R, Mitsushima T, Cholelithiasis is a risk factor for colorectal adenoma. Am J Gastroenterol 2008;103:2847–52.
  • Hassan C, Pickhardt PJ, Marmo R, Choi JR. Impact of lifestyle factors on colorectal polyp detection in the screening setting. Dis Colon Rectum 2010;53:1328–33.
  • Park SK, Joo JS, Kim DH, Kim YE, Kang D, Yoo KY. Association of serum lipids and glucose with the risk of colorectal adenomatous polyp in men: a case-control study in Korea. J Korean Med Sci 2000;15:690–5.
  • Chung YW, Han DS, Park YK, Son BK, Paik CH, Lee HL, Association of obesity, serum glucose and lipids with the risk of advanced colorectal adenoma and cancer: a case-control study in Korea. Dig Liver Dis 2006;38:668–72.
  • Omata F, Brown WR, Tokuda Y, Takahashi O, Fukui T, Ueno F, Modifiable risk factors for colorectal neoplasms and hyperplastic polyps. Intern Med 2009;48:123–8.
  • Betes M, Munoz-Navas MA, Duque JM, Angos R, Macias E, Subtil JC, Use of colonoscopy as a primary screening test for colorectal cancer in average risk people. Am J Gastroenterol 2003;98:2648–54.
  • Wallace K, Baron JA, Karagas MR, Cole BF, Byers T, Beach MA, The association of physical activity and body mass index with the risk of large bowel polyps. Cancer Epidemiol Biomarkers Prev 2005;14:2082–6.
  • Hermann S, Rohrmann S, Linseisen J. Lifestyle factors, obesity and the risk of colorectal adenomas in EPIC-Heidelberg. Cancer Causes Control 2009;20:1397–408.
  • Nock NL, Plummer SJ, Thompson CL, Casey G, Li L. FTO polymorphisms are associated with adult body mass index (BMI) and colorectal adenomas in African-Americans. Carcinogenesis 2011;32:748–56.
  • Terry MB, Neugut AI, Bostick RM, Sandler RS, Haile RW, Jacobson JS, Risk factors for advanced colorectal adenomas: a pooled analysis. Cancer Epidemiol Biomarkers Prev 2002;11:622–9.
  • Morimoto LM, Newcomb PA, Ulrich CM, Bostick RM, Lais CJ, Potter JD. Risk factors for hyperplastic and adenomatous polyps: evidence for malignant potential? Cancer Epidemiol Biomarkers Prev 2002;11:1012–18.
  • Hauret KG, Bostick RM, Matthews CE, Hussey JR, Fina MF, Geisinger KR, Physical activity and reduced risk of incident sporadic colorectal adenomas: observational support for mechanisms involving energy balance and inflammation modulation. Am J Epidemiol 2004;159:983–92.
  • Wernli KJ, Newcomb PA, Wang Y, Makar KW, Shadman M, Chia VM, Body size, IGF and growth hormone polymorphisms, and colorectal adenomas and hyperplastic polyps. Growth Horm IGF Res 2010;20:305–9.
  • Anderson JC, Messina CR, Dakhllalah F, Abraham B, Alpern Z, Martin C, Body mass index: a marker for significant colorectal neoplasia in a screening population. J Clin Gastroenterol 2007;41:285–90.
  • Lee GE, Park HS, Yun KE, Jun SH, Kim HK, Cho SI, Association between BMI and metabolic syndrome and adenomatous colonic polyps in Korean men. Obesity 2008;16:1434–9.
  • Kim Y, Lee S. An association between colonic adenoma and abdominal obesity: a cross-sectional study. BMC Gastroenterol 2009;9:4.
  • Nam SY, Kim BC, Han KS, Ryu KH, Park BJ, Kim HB, Abdominal visceral adipose tissue predicts risk of colorectal adenoma in both sexes. Clin Gastroenterol Hepatol 2010;8:443–50; e1-2.
  • Huang L, Wang X, Gong W, Huang Y, Jiang B. The comparison of the clinical manifestations and risk factors of colorectal cancer and adenomas: results from a colonoscopy-based study in southern Chinese. Int J Colorectal Dis 2010;25:1343–51.
  • Tsilidis KK, Brancati FL, Pollak MN, Rifai N, Clipp SL, Hoffman-Bolton J, Metabolic syndrome components and colorectal adenoma in the CLUE II cohort. Cancer Causes Control 2010;21:1–10.
  • Morois S, Mesrine S, Josset M, Clavel-Chapelon F, Boutron-Ruault MC. Anthropometric factors in adulthood and risk of colorectal adenomas: the French E3N-EPIC prospective cohort. Am J Epidemiol 2010;172:1166–80.
  • Olsen J, Kronborg O, Lynggaard J, Ewertz M. Dietary risk factors for cancer and adenomas of the large intestine. A case-control study within a screening trial in Denmark. Eur J Cancer 1994;30A:53–60.
  • Bird CL, Frankl HD, Lee ER, Haile RW. Obesity, weight gain, large weight changes, and adenomatous polyps of the left colon and rectum. Am J Epidemiol 1998;147:670–80.
  • Schoen RE, Weissfeld JL, Kuller LH, Thaete FL, Evans RW, Hayes RB, Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps. Gastroenterology 2005;129:464–75.
  • Wolf LA, Terry PD, Potter JD, Bostick RM. Do factors related to endogenous and exogenous estrogens modify the relationship between obesity and risk of colorectal adenomas in women? Cancer Epidemiol Biomarkers Prev 2007;16:676–83.
  • Honjo S, Kono S, Shinchi K, Wakabayashi K, Todoroki I, Sakurai Y, The relation of smoking, alcohol use and obesity to risk of sigmoid colon and rectal adenomas. Japn J Cancer Res 1995;86:1019–26.
  • Larsen IK, Grotmol T, Almendingen K, Hoff G. Lifestyle as a predictor for colonic neoplasia in asymptomatic individuals. BMC Gastroenterol 2006;6:5.
  • Giovannucci E, Colditz GA, Stampfer MJ, Willett WC. Physical activity, obesity, and risk of colorectal adenoma in women (United States). Cancer Causes Control 1996;7:253–63.
  • Neugut AI, Lee WC, Garbowski GC, Waye JD, Forde KA, Treat MR, Obesity and colorectal adenomatous polyps. J Natl Cancer Inst 1991;83:359–61.
  • Boutron-Ruault MC, Senesse P, Meance S, Belghiti C, Faivre J. Energy intake, body mass index, physical activity, and the colorectal adenoma-carcinoma sequence. Nutr Cancer 2001;39:50–7.
  • Le Marchand L, Wang H, Rinaldi S, Kaaks R, Vogt TM, Yokochi L, Associations of plasma C-peptide and IGFBP-1 levels with risk of colorectal adenoma in a multiethnic population. Cancer Epidemiol Biomarkers Prev 2010;19:1471–7.
  • Lieberman DA, Prindiville S, Weiss DG, Willett W. Risk factors for advanced colonic neoplasia and hyperplastic polyps in asymptomatic individuals. JAMA 2003;290:2959–67.
  • Yamamoto S, Nakagawa T, Matsushita Y, Kusano S, Hayashi T, Irokawa M, Visceral fat area and markers of insulin resistance in relation to colorectal neoplasia. Diabetes Care 2010;33:184–9.
  • Kahn HS, Tatham LM, Thun MJ, Heath CW Jr. Risk factors for self-reported colon polyps. J Gen Intern Med 1998;13:303–10.
  • Wise LA, Rosenberg L, Palmer JR, Adams-Campbell LL. Anthropometric risk factors for colorectal polyps in African-American women. Obesity 2008;16:859–68.
  • Jacobs ET, Ahnen DJ, Ashbeck EL, Baron JA, Greenberg ER, Lance P, Association between body mass index and colorectal neoplasia at follow-up colonoscopy: a pooling study. Am J Epidemiol 2009;169:657–66.
  • Teramukai S, Rohan T, Lee KY, Eguchi H, Oda T, Kono S. Insulin-like growth factor (IGF)-I, IGF-binding protein-3 and colorectal adenomas in Japanese men. Jpn J Cancer Res 2002;93:1187–94.
  • Kim JH, Lim YJ, Kim YH, Sung IK, Shim SG, Oh SO, Is metabolic syndrome a risk factor for colorectal adenoma? Cancer Epidemiol Biomarkers Prev 2007;16:1543–6.
  • Takahashi H, Takayama T, Yoneda K, Endo H, Iida H, Sugiyama M, Association of visceral fat accumulation and plasma adiponectin with rectal dysplastic aberrant crypt foci in a clinical population. Cancer Sci 2009;100:29–32.
  • Calle EE, Rodriguez C, Walker-Thurmond K, Thun MJ. Overweight, obesity, and mortality from cancer in a prospectively studied cohort of U.S. adults. N Engl J Med 2003;348:1625–38.
  • Wei EK, Giovannucci E, Fuchs CS, Willett WC, Mantzoros CS. Low plasma adiponectin levels and risk of colorectal cancer in men: a prospective study. J Natl Cancer Inst 2005;97:1688–94.
  • Yamaji T, Iwasaki M, Sasazuki S, Tsugane S. Interaction between adiponectin and leptin influences the risk of colorectal adenoma. Cancer Res 2010;70:5430–7.
  • Nakajima TE, Yamada Y, Hamano T, Furuta K, Matsuda T, Fujita S, Adipocytokines as new promising markers of colorectal tumors: adiponectin for colorectal adenoma, and resistin and visfatin for colorectal cancer. Cancer Sci 2010;101:1286–91.
  • Otake S, Takeda H, Fujishima S, Fukui T, Orii T, Sato T, Decreased levels of plasma adiponectin associated with increased risk of colorectal cancer. World J Gastroenterol 2010;16:1252–7.
  • Erarslan E, Turkay C, Koktener A, Koca C, Uz B, Bavbek N. Association of visceral fat accumulation and adiponectin levels with colorectal neoplasia. Dig Dis Sci 2009;54:862–8.
  • Fujisawa T, Endo H, Tomimoto A, Sugiyama M, Takahashi H, Saito S, Adiponectin suppresses colorectal carcinogenesis under the high-fat diet condition. Gut 2008;57:1531–8.
  • Endo H, Hosono K, Uchiyama T, Sakai E, Sugiyama M, Takahashi H, Leptin acts as a growth factor for colorectal tumours at stages subsequent to tumour initiation in murine colon carcinogenesis. Gut 2011;60:1363–71.
  • Mutoh M, Teraoka N, Takasu S, Takahashi M, Onuma K, Yamamoto M, Loss of adiponectin promotes intestinal carcinogenesis in Min and wild-type mice. Gastroenterology 2011;140:2000–8.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.